Building the Future of Neurological Cures

A B2B PaaS for CNS Drug Screening
at the frontier of NeuroBio, AI, and Robotics

Brain Organoids

Standardized biomanufacture of 3D brain cultures at scale through automated wet labs.

Ensuring consistent quality and reproducibility in drug screening processes, making it a cornerstone for advancing human-relevant CNS drug discovery.

Virtual Connectomes

Whole-circuit digital twins for comprehensive long-term monitoring.

Bridging the in-vitro / in-silico gap to provide high-fidelity unfolding of disease and enhanced drug screening accuracy.

Computational Signatures

Multimodal NeuroBio Foundation models uncovering signatures of brain pathologies.

Leveraging multi-scale data, from spatial transcriptomics to network dynamics, to develop precise computational measures that predict deviations from healthy baselines.

About Us

We are a team of AI, neuroscience, and bioengineering experts
dedicated to advancing neurological drug development.